Tag Archives: Xarelto
New York Property Owners Challenge Binghamton Fracking Ban
According to a Reuters report, the landowners believe the Binghamton, N.Y., city council and Mayor acted against proper protocol when voting to ban fracking drilling the the city. Instead, they feel the city should have consulted with the Broome County Planning Commission before approving the ban.
Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System
Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...
Study Finds System for Tracking Prescription Drug Side Effects Flawed
System for keeping track of dangerous side effects of prescription drugs is flawed because drug makers are submitting incomplete information about problems to the FDA.
Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors
Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.
Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business
Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...
British Recall of Smith & Nephew Renasys Wound Care System for Infection Risk
The MHRA announced the recall of Smith & Nephew Renasys wound care devices - risk of maceration, infection, loss of negative pressure, or unrecognized bleeding in wounds.
FDA Gives 7 Companies Go Ahead To Market Generic Plavix
The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...
Newly-Filed Plavix Lawsuits Claim Drug Caused Gastrointestinal Bleeds, Cerebral Hemorrhage, and TTP
The manufacturer of Plavix continues to be named in lawsuits alleging the blood thinner caused some patients to suffer from serious bleeding side effects. Most recently, the national law firm of Parker Waichman LLP filed nine Plavix bleeding lawsuits in state court in New York.
Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit
A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it in the U.S., claiming they failed to warn about this ...Xarelto Manufacturer Leads Spending for Physicians’ Favor
The public-interest news organization ProPublica issued a new report that indicates manufacturers spent more in 2015 on physician payments for Xarelto than any other drug. These payments were not for research, but for things like consulting, meals, travel, promotional speaking, … Continue reading
Pretrial Proceedings Moving Forward in First Four Xarelto Bellwether Cases
In a recent court order, Judge Eldon Fallon, who oversees the Xarelto multidistrict litigation in the Eastern District of Louisiana, outlined the schedule for the first four trials. Judge Fallon has selected four cases to serve as the first bellwether … Continue reading
Xarelto Plaintiffs Hope for Outcome Similar to Pradaxa Settlement
The current multidistrict litigation (MDL) comprised of more than 7,000 Xarelto (rivoxaban) lawsuits filed against the Johnson & Johnson subsidiary, Janssen Pharmaceuticals, and Bayer AG is being overseen by the Honorable Judge Eldon E. Fallon in the Eastern District of … Continue reading
Xarelto Plaintiffs have More Time to File Lawsuits
Due to the number of Xarelto lawsuits that have flooded the clerk’s office, Judge Eldon Fallon has extended the filing deadline by 90 days. There are more than 7,000 lawsuits pending in the multidistrict litigation in the Eastern District of … Continue reading
In Xarelto MDL, Judge Extends Deadline to File Complaints
Certain groups of plaintiffs in the Xarelto multidistrict litigation (MDL) have more time to file a lawsuit against manufacturers Janssen Pharmaceuticals and Bayer Healthcare. According to a recent order issued by Judge Eldon Fallon, who is overseeing the MDL in … Continue reading
Quality of Xarelto Clinical Trials Expected to be an Issue in 2017 Court Cases
When the first lawsuits involving the blood-thinning drug Xarelto go to trial in 2017, attorneys expect the quality of the clinical trials involved in the drug’s approval to be a major issue. Xarelto lawsuits have been filed in both federal … Continue reading
Xarelto Lawsuits Continue to Mount, Clinical Trials Under Scrutiny
According to court records, Bayer AG and Janssen Pharmaceuticals are facing close to 6,000 lawsuits alleging that the companies failed to warn about the risks associated with Xarelto, an anti-coagulant drug. Plaintiffs in the litigation allege that the blood thinner … Continue reading
Bellwether Trial Dates in Xarelto Litigation Scheduled for 2017
Bellwether trial dates have been selected in the Xarelto multidistrict litigation (MDL) 2592. Court records show that more than 2,800 lawsuits have been consolidated into the MDL in Eastern Louisiana before U.S. District Judge Eldon E. Fallon. A list of … Continue reading
Lawsuit Alleges Eliquis Caused Fatal Hemorrhaging, Drug Makers Failed to Warn
Pfizer and Bristol-Myers Squibb are facing a wrongful death lawsuit alleging that the companies failed to warn about the risk of irreversible bleeding with Eliquis (apixaban), an anticoagulant. The lawsuit was filed on behalf of a woman whose husband began … Continue reading
Xarelto Led to Uncontrollable, Fatal Bleeding, Lawsuit Alleges
A woman in Vermont has filed a lawsuit alleging that her father suffered a fatal, uncontrollable brain bleed after taking the anticoagulant Xarelto. The lawsuit alleges that Bayer AG and Janssen Pharmaceuticals failed to warn about the risk of irreversible … Continue reading
